• Introduced
    Jan 08, 2021
  • Passed House
    Jan 27, 2021
  • Passed Senate
    Mar 23, 2021
  • Became Law
    Apr 01, 2021
HB 1139
North Dakota House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
Relating to duration limits for opioid therapy and benzodiazepine; and to provide for application.
Last Action See all actions
executive • Apr 05, 2021: Filed with Secretary Of State 04/01
Latest Bill Text See all bill texts

Summary

Comments on HB 1139

Tweets

Whip Lists

Sponsors
Votes
Actions
  • Apr 05, 2021 | executive
    • Filed with Secretary Of State 04/01
  • Apr 01, 2021 | House
    • Signed by Governor 03/31
  • Mar 29, 2021 | House
    • Signed by Speaker
    • Sent to Governor
  • Mar 25, 2021 | Senate
    • Signed by President
  • Mar 24, 2021 | House
    • Returned to House
  • Mar 23, 2021 | Senate
    • Second reading, passed, yeas 38 nays 8
  • Mar 22, 2021 | Senate
    • Reported back, do pass, place on calendar 5 1 0
  • Mar 08, 2021 | Senate
    • Bill Hearing, Senate Industry, Business and Labor, 03/08 2:30 PM, Room Fort Union - relating to duration limits for opioid therapy and benzodiazepine
    • Committee Hearing 02:30
  • Feb 15, 2021 | Senate
    • Introduced, first reading, referred Industry, Business and Labor Committee
  • Jan 28, 2021 | Senate
    • Received from House
  • Jan 27, 2021 | House
    • Second reading, passed, yeas 64 nays 26
  • Jan 21, 2021 | House
    • Reported back, do pass, place on calendar 12 1 1
  • Jan 18, 2021 | House
    • Bill Hearing, House Industry, Business and Labor, 01/18 8:00 AM, Room 327C - Duration limits for opioid therapy & benzodiazepine.
    • Committee Hearing 08:00
  • Jan 08, 2021 | House
    • Introduced, first reading, referred Industry, Business and Labor Committee
Documents